Application of the Comstock Act to the Mailing of Prescription Drugs That Can Be Used for Abortions

CourtDepartment of Justice Office of Legal Counsel
DecidedDecember 23, 2022
StatusPublished

This text of Application of the Comstock Act to the Mailing of Prescription Drugs That Can Be Used for Abortions (Application of the Comstock Act to the Mailing of Prescription Drugs That Can Be Used for Abortions) is published on Counsel Stack Legal Research, covering Department of Justice Office of Legal Counsel primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Application of the Comstock Act to the Mailing of Prescription Drugs That Can Be Used for Abortions, (olc 2022).

Opinion

(Slip Opinion)

Application of the Comstock Act to the Mailing of Prescription Drugs That Can Be Used for Abortions Section 1461 of title 18 of the U.S. Code does not prohibit the mailing of certain drugs that can be used to perform abortions where the sender lacks the intent that the recipi- ent of the drugs will use them unlawfully. Because there are manifold ways in which recipients in every state may lawfully use such drugs, including to produce an abor- tion, the mere mailing of such drugs to a particular jurisdiction is an insufficient basis for concluding that the sender intends them to be used unlawfully.

December 23, 2022

MEMORANDUM OPINION FOR THE GENERAL COUNSEL UNITED STATES POSTAL SERVICE

In the wake of the United States Supreme Court’s recent decision over- ruling Roe v. Wade, 410 U.S. 113 (1973), 1 you have asked for this Of- fice’s view on whether section 1461 of title 18 of the United States Code prohibits the mailing of mifepristone and misoprostol, two prescription drugs that are commonly used to produce abortions, 2 among other purpos- es. Memorandum for Christopher Schroeder, Assistant Attorney General, Office of Legal Counsel, from Thomas J. Marshall, General Counsel, United States Postal Service, Re: Request for an Interpretation of 18 U.S.C. § 1461, at 1 (July 1, 2022) (“USPS Request”). Originally enacted as part of the Comstock Act of 1873, section 1461 currently declares “[e]very article or thing designed, adapted, or intended for producing abortion,” as well as “[e]very article, instrument, substance, drug, medi- cine, or thing which is advertised or described in a manner calculated to lead another to use or apply it for producing abortion,” to be “nonmailable matter” that the United States Postal Service (“USPS”) may not lawfully deliver. 18 U.S.C. § 1461. We conclude that section 1461 does not prohibit the mailing, or the de- livery or receipt by mail, of mifepristone or misoprostol where the sender

1 See Dobbs v. Jackson Women’s Health Org., 142 S. Ct. 2228 (2022). 2 See Ctrs. for Disease Control & Prevention, U.S. Dep’t of Health & Hum. Servs., Abortion Surveillance—United States, 2019, 70 MMWR Surveillance Summaries, Nov. 26, 2019, at 8, https://www.cdc.gov/mmwr/volumes/70/ss/ss7009a1.htm.

1 46 Op. O.L.C. __ (Dec. 23, 2022)

lacks the intent that the recipient of the drugs will use them unlawfully. 3 This conclusion is based upon a longstanding judicial construction of the Comstock Act, which Congress ratified and USPS itself accepted. Federal law does not prohibit the use of mifepristone and misoprostol. Indeed, the U.S. Food and Drug Administration (“FDA”) has determined the use of mifepristone in a regimen with misoprostol to be safe and effective for the medical termination of early pregnancy. 4 Moreover, there are manifold ways in which recipients in every state may use these drugs, including to produce an abortion, without violating state law. Therefore, the mere mailing of such drugs to a particular jurisdiction is an insufficient basis for concluding that the sender intends them to be used unlawfully. 5

3 A cognate provision, 18 U.S.C. § 1462, imposes similar abortion-related prohibitions on using an express company or other common carrier for “carriage” of such items. Our analysis in this memorandum is applicable to that provision as well. Sections 1461 and 1462 refer not only to persons who transmit such items by mail or by common carrier—the senders—but also to individuals who “knowingly cause[]” such items to be mailed, id. § 1461; “knowingly take[]” any such items from the mail for the purpose of circulating or disposing of them, id.; or “knowingly take[] or receive[]” such items from an express company or common carrier, id. § 1462. In the different contexts of obscenity and child pornography, courts of appeals have held that section 1461 applies to the act of the recipient who orders the nonmailable material and thereby “causes” it to be mailed. See, e.g., United States v. Carmack, 910 F.2d 748, 748 (11th Cir. 1990); United States v. Johnson, 855 F.2d 299, 305–06 (6th Cir. 1988). But see Johnson, 855 F.2d at 307–11 (Merritt, J., dissenting); United States v. Sidelko, 248 F. Supp. 813, 815 (M.D. Pa. 1965). As far as we know, however, these provisions have never been applied to prose- cute the recipients of abortion- and contraception-related materials. Moreover, the court of appeals decisions we discuss below construed the relevant provisions of the Comstock Act to turn on the nature of the sender’s intent, not that of the recipient. Consistent with this practice, we focus on the sender throughout this memorandum. To the extent a recipient might be covered, however, our analysis herein would apply and therefore section 1461 would not prohibit that person from ordering or receiving the drugs if she does not intend that they be used unlawfully. 4 See Mifeprex (Mifepristone) Tablets, U.S. Food & Drug Admin. 2 (Mar. 2016),

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020687s022lbl.pdf (mifepris- tone label); see also Mifeprex (Mifepristone) Information, U.S. Food & Drug Admin., https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers /mifeprex-mifepristone-information (last updated Dec. 16, 2021). 5 For purposes of this opinion, we assume but do not decide that section 1461 could be

constitutionally applied to the mailing of drugs intended to produce abortions. We also assume without deciding that state law, as well as federal, is relevant to the application of section 1461. In addition, we do not address here whether and under what circumstances the mailing of mifepristone or misoprostol might violate other federal laws. Finally, as

2 Application of the Comstock Act to Drugs That Can Be Used for Abortions

I.

The Comstock Act has a long and complex history. The original 1873 law was the handiwork of Anthony Comstock—“a prominent anti-vice crusader who believed that anything remotely touching upon sex was . . . obscene”—who successfully lobbied Congress and state legislatures in the nineteenth century to enact expansive laws “to prevent the mails from being used to corrupt the public morals.” Bolger v. Youngs Drug Prods. Corp., 463 U.S. 60, 70 n.19 (1983) (omission in original) (quotation marks and citations omitted); see also Priscilla J. Smith, Contraceptive Comstockery: Reasoning from Immorality to Illness in the Twenty-First Century, 47 Conn. L. Rev. 971, 982–84 (2015). Originally entitled “An Act for the Suppression of Trade in, and Circulation of, obscene Litera- ture and Articles of immoral Use,” Act of Mar. 3, 1873, ch. 258, 17 Stat. 598 (“1873 Act”), the Act is perhaps best known for having prohibited the distribution of a wide range of writings until courts and the Executive Branch determined that the Free Speech Clause of the First Amendment significantly limited the permissible reach of the law, see, e.g., Bolger, 463 U.S. at 69–75.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ex Parte Collett
337 U.S. 55 (Supreme Court, 1949)
Poe v. Ullman
367 U.S. 497 (Supreme Court, 1961)
Griswold v. Connecticut
381 U.S. 479 (Supreme Court, 1965)
United States v. Guest
383 U.S. 745 (Supreme Court, 1966)
Roe v. Wade
410 U.S. 113 (Supreme Court, 1973)
Bigelow v. Virginia
421 U.S. 809 (Supreme Court, 1975)
Muniz v. Hoffman
422 U.S. 454 (Supreme Court, 1975)
Smith v. United States
431 U.S. 291 (Supreme Court, 1977)
Lorillard v. Pons
434 U.S. 575 (Supreme Court, 1978)
Bolger v. Youngs Drug Products Corp.
463 U.S. 60 (Supreme Court, 1983)
Bragdon v. Abbott
524 U.S. 624 (Supreme Court, 1998)
Forest Grove School District v. T. A.
557 U.S. 230 (Supreme Court, 2009)
United States v. Lee R. Johnson
855 F.2d 299 (Sixth Circuit, 1988)
United States v. James Melvin Carmack
910 F.2d 748 (Eleventh Circuit, 1990)
United States v. Sidelko
248 F. Supp. 813 (M.D. Pennsylvania, 1965)
Davis v. United States
62 F.2d 473 (Sixth Circuit, 1933)
Consumers Union of United States, Inc. v. Walker
145 F.2d 33 (D.C. Circuit, 1944)
Youngs Rubber Corporation v. CI Lee & Co.
45 F.2d 103 (Second Circuit, 1930)
United States v. Nicholas
97 F.2d 510 (Second Circuit, 1938)

Cite This Page — Counsel Stack

Bluebook (online)
Application of the Comstock Act to the Mailing of Prescription Drugs That Can Be Used for Abortions, Counsel Stack Legal Research, https://law.counselstack.com/opinion/application-of-the-comstock-act-to-the-mailing-of-prescription-drugs-that-olc-2022.